A Phase II Study to Evaluate the Efficacy of Regorafenib in C-KIT Mutated Metastatic Malignant Melanoma Patients Who Have Progressed on First-Line Treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13)
European Journal of Cancer（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined